Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies' professionals in the European Economic Area.

Urszula WŁodarczak Damian ŚWieczkowski Urszula Religioni Milosz Jaroslaw Jaguszewski Jerzy Krysinski Piotr Merks

Published in: Pharmacy practice (2017)

Awareness of the regulations related to the implementation of the FMD, although relatively high among pharmaceutical company professionals in the EEA, is still insufficient.

Keyphrases

primary care
healthcare
quality improvement
drug induced